The ELEVATE Study shows that atogepant effectively prevents episodic migraine.

Published Date: 24 Apr 2023

Atogepant (Qulipta) performed better than a placebo in the ELEVATE study for preventing episodic migraine in patients who were resistant to other treatments.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Advances in TNBC; Mixed News in Lung Cancer Report; Pancreatic Cancer Overdiagnosis?

2.

For Localized Prostate Cancer, HIFU Is Not Worse Than Prostatectomy.

3.

Reducing social media to an hour a day boosts young people's self-image.

4.

Squeezing through tiny blood vessels may trigger melanoma cells to spread

5.

Despite reports of hundreds of cancer cases, carcinogens have been discovered at nuclear missile sites in Montana.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot